Experts discuss the necessity of ESR1 mutation testing when considering treatment with elacestrant in patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer and ...

Integrating HER2-directed therapies into NSCLC decision-making requires adapting protocols and ensuring timely updates as new therapies emerge. Streamlined processes and enhanced communication among ...

I was 18 when my mom was diagnosed with breast cancer. It altered the trajectory of my second year at college and changed how I viewed my mom, whom I naively thought was exempt from harm. She knew ...

We offer targeted detection of a previously characterized mutation within the family. From a fresh EDTA blood sample, DNA is extracted directly and the target region is amplified and directly ...

Circulating tumor (ctDNA) is increasingly used for cancer diagnosis and monitoring. ESMO and ASCO recognize the clinical utility of liquid biopsy for diagnostic purposes and to identify actionable ...

Dr. Angie DeMichele and Dr. Lynn Henry present the latest rapid recommendation impacting two ASCO guidelines. This update focuses on testing for ESR1 mutations in patients with hormone ...

Genetic testing can confirm a muscular dystrophy (MD) diagnosis when symptoms and other tests already suggest MD. It also identifies specific gene mutations that can guide targeted treatment. Genetic ...

Mutation rates and biases in mutational sequence context can be influenced by endogenous cellular processes, environmental exposures, and genetic variation. All such mutagenic processes can leave ...

Cystic fibrosis is an inherited illness that can be screened for during pregnancy. The test determines whether you have any altered genes that you can pass on to your child. Having the information can ...

Deepak Gupta, VP Engineering at Cars24. Specializes in FinTech, AI/ML, E-comm, digital transformation, business strategy and revenue growth. Software systems are getting more complex, like a giant ...